{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Preprocess Required for Generating Train Data: "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import urllib.request\n",
    "import time\n",
    "import sys\n",
    "import getopt\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import pickle\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "%run ../utils.ipynb"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "embSize = 200\n",
    "\n",
    "ftrain='../data/EUADR_target_disease.csv'\n",
    "# Replace with path of word embdding file   \n",
    "#wefile = \"/mnt/admin/GDA_backup/Dataset/embeddings/PubMed-and-PMC-w2v.bin\"\n",
    "wefile = \"../support/PubMed-and-PMC-w2v.bin\"\n",
    "random_seed=1331"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\"ASSOCIATION_TYPE\"\t\"PMID\"\t\"NUM_SENTENCE\"\t\"ENTITY1_TEXT\"\t\"ENTITY1_INI\"\t\"ENTITY1_END\"\t\"ENTITY1_TYPE\"\t\"ENTITY2_TEXT\"\t\"ENTITY2_INI\"\t\"ENTITY2_END\"\t\"ENTITY2_TYPE\"\t\"SENTENCE\"\n",
      "\n",
      "+----+--------------------+----------+----------------+-------------------+---------------+---------------+-----------------------------+-------------------+---------------+---------------+----------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|    | ASSOCIATION_TYPE   |     PMID |   NUM_SENTENCE | ENTITY1_TEXT      |   ENTITY1_INI |   ENTITY1_END | ENTITY1_TYPE                | ENTITY2_TEXT      |   ENTITY2_INI |   ENTITY2_END | ENTITY2_TYPE         | SENTENCE                                                                                                                                               |\n",
      "+====+====================+==========+================+===================+===============+===============+=============================+===================+===============+===============+======================+========================================================================================================================================================+\n",
      "|  0 | SA                 | 17241106 |             16 | LRP5              |            19 |            23 | Genes & Molecular Sequences | osteoporosis      |            80 |            92 | Diseases & Disorders | Our work supported LRP5 genetic variants as possible susceptibility factors for osteoporosis and fractures in humans.                                  |\n",
      "+----+--------------------+----------+----------------+-------------------+---------------+---------------+-----------------------------+-------------------+---------------+---------------+----------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  1 | SA                 | 17241106 |             17 | rs491347          |            20 |            28 | SNP & Sequence variations   | osteoporosis      |           108 |           120 | Diseases & Disorders | Especially, the SNP rs491347 and its strongly associated SNPs (e.g., rs1784235) could be important to human osteoporosis phenotypes.                   |\n",
      "+----+--------------------+----------+----------------+-------------------+---------------+---------------+-----------------------------+-------------------+---------------+---------------+----------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  2 | SA                 | 17241106 |             17 | rs1784235         |            69 |            78 | SNP & Sequence variations   | osteoporosis      |           108 |           120 | Diseases & Disorders | Especially, the SNP rs491347 and its strongly associated SNPs (e.g., rs1784235) could be important to human osteoporosis phenotypes.                   |\n",
      "+----+--------------------+----------+----------------+-------------------+---------------+---------------+-----------------------------+-------------------+---------------+---------------+----------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  3 | FA                 | 18697826 |              0 | fetal haemoglobin |            93 |           110 | Genes & Molecular Sequences | beta-thalassaemia |           132 |           149 | Diseases & Disorders | The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia. |\n",
      "+----+--------------------+----------+----------------+-------------------+---------------+---------------+-----------------------------+-------------------+---------------+---------------+----------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------+\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "from tabulate import tabulate\n",
    "ftrain = '../data/EUADR_target_disease.csv'\n",
    "with open(ftrain, 'r', encoding='latin1') as file:\n",
    "    first_line = file.readline()\n",
    "    print(first_line)\n",
    "import pandas as pd\n",
    "\n",
    "ftrain = '../data/EUADR_target_disease.csv'\n",
    "\n",
    "# Specify the delimiter for tabs\n",
    "df = pd.read_csv(ftrain, encoding='latin1', sep='\\t')\n",
    "\n",
    "\n",
    "# Display the first 10 rows of the DataFrame as a table\n",
    "print(tabulate(df.head(4), headers='keys', tablefmt='grid'))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "First line of the file: \"ASSOCIATION_TYPE\"\t\"PMID\"\t\"NUM_SENTENCE\"\t\"ENTITY1_TEXT\"\t\"ENTITY1_INI\"\t\"ENTITY1_END\"\t\"ENTITY1_TYPE\"\t\"ENTITY2_TEXT\"\t\"ENTITY2_INI\"\t\"ENTITY2_END\"\t\"ENTITY2_TYPE\"\t\"SENTENCE\"\n",
      "\n",
      "Column names: Index(['ASSOCIATION_TYPE', 'PMID', 'NUM_SENTENCE', 'ENTITY1_TEXT',\n",
      "       'ENTITY1_INI', 'ENTITY1_END', 'ENTITY1_TYPE', 'ENTITY2_TEXT',\n",
      "       'ENTITY2_INI', 'ENTITY2_END', 'ENTITY2_TYPE', 'SENTENCE'],\n",
      "      dtype='object')\n",
      "Unique association types: ['SA' 'FA' 'PA' nan]\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|    | ASSOCIATION_TYPE   |     PMID |   NUM_SENTENCE | ENTITY1_TEXT                    |   ENTITY1_INI |   ENTITY1_END | ENTITY1_TYPE                | ENTITY2_TEXT                           |   ENTITY2_INI |   ENTITY2_END | ENTITY2_TYPE         | SENTENCE                                                                                                                                                                                                                                                                                                                                                                                                                                           |\n",
      "+====+====================+==========+================+=================================+===============+===============+=============================+========================================+===============+===============+======================+====================================================================================================================================================================================================================================================================================================================================================================================================================================================+\n",
      "|  0 | SA                 | 17241106 |             16 | LRP5                            |            19 |            23 | Genes & Molecular Sequences | osteoporosis                           |            80 |            92 | Diseases & Disorders | Our work supported LRP5 genetic variants as possible susceptibility factors for osteoporosis and fractures in humans.                                                                                                                                                                                                                                                                                                                              |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  1 | SA                 | 17241106 |             17 | rs491347                        |            20 |            28 | SNP & Sequence variations   | osteoporosis                           |           108 |           120 | Diseases & Disorders | Especially, the SNP rs491347 and its strongly associated SNPs (e.g., rs1784235) could be important to human osteoporosis phenotypes.                                                                                                                                                                                                                                                                                                               |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  2 | SA                 | 17241106 |             17 | rs1784235                       |            69 |            78 | SNP & Sequence variations   | osteoporosis                           |           108 |           120 | Diseases & Disorders | Especially, the SNP rs491347 and its strongly associated SNPs (e.g., rs1784235) could be important to human osteoporosis phenotypes.                                                                                                                                                                                                                                                                                                               |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  3 | FA                 | 18697826 |              0 | fetal haemoglobin               |            93 |           110 | Genes & Molecular Sequences | beta-thalassaemia                      |           132 |           149 | Diseases & Disorders | The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia.                                                                                                                                                                                                                                                                                             |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  4 | PA                 | 18697826 |              1 | HbF                             |            19 |            22 | Genes & Molecular Sequences | HBB disorders                          |            64 |            77 | Diseases & Disorders | Fetal haemoglobin (HbF) level modifies the clinical severity of HBB disorders.                                                                                                                                                                                                                                                                                                                                                                     |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  5 | PA                 | 18697826 |              1 | Fetal haemoglobin               |             0 |            17 | Genes & Molecular Sequences | HBB disorders                          |            64 |            77 | Diseases & Disorders | Fetal haemoglobin (HbF) level modifies the clinical severity of HBB disorders.                                                                                                                                                                                                                                                                                                                                                                     |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  6 | FA                 | 18697826 |              0 | HBS1L-MYB                       |             4 |            13 | Genes & Molecular Sequences | beta-thalassaemia                      |           132 |           149 | Diseases & Disorders | The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia.                                                                                                                                                                                                                                                                                             |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  7 | FA                 | 18697826 |              0 | 6q23                            |            46 |            50 | Genes & Molecular Sequences | beta-thalassaemia                      |           132 |           149 | Diseases & Disorders | The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia.                                                                                                                                                                                                                                                                                             |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  8 | FA                 | 18697826 |              7 | HbF                             |            87 |            90 | Genes & Molecular Sequences | HBB disorders                          |           196 |           209 | Diseases & Disorders | Functional studies to unravel the biological significance of this region in regulating HbF production is clearly indicated, which may lead to new strategies to modify the disease course of severe HBB disorders.                                                                                                                                                                                                                                 |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  9 | PA                 | 18322311 |              0 | TNFalpha gene polymorphisms     |            16 |            43 | Genes & Molecular Sequences | multiple sclerosis                     |            69 |            87 | Diseases & Disorders | IL-1, IL-1R and TNFalpha gene polymorphisms in Iranian patients with multiple sclerosis.                                                                                                                                                                                                                                                                                                                                                           |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "| 10 | FA                 | 18322311 |              7 | IL-1alpha TT -889               |            35 |            52 | SNP & Sequence variations   | multiple sclerosis                     |           406 |           424 | Diseases & Disorders | On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), TNFalpha G -308 allele (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian multiple sclerosis patients. |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "| 11 | PA                 | 18322311 |              7 | TNFalpha G -308 allele          |           138 |           160 | Genes & Molecular Sequences | multiple sclerosis                     |           406 |           424 | Diseases & Disorders | On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), TNFalpha G -308 allele (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian multiple sclerosis patients. |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "| 12 | PA                 | 18322311 |              0 | IL-1                            |             0 |             4 | Genes & Molecular Sequences | multiple sclerosis                     |            69 |            87 | Diseases & Disorders | IL-1, IL-1R and TNFalpha gene polymorphisms in Iranian patients with multiple sclerosis.                                                                                                                                                                                                                                                                                                                                                           |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "| 13 | PA                 | 18347176 |              0 | T393C polymorphism of the GNAS1 |           127 |           158 | SNP & Sequence variations   | oropharyngeal                          |            37 |            50 | Diseases & Disorders | Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene.                                                                                                                                                                                                                                                                               |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "| 14 | PA                 | 18347176 |              0 | T393C polymorphism of the GNAS1 |           127 |           158 | SNP & Sequence variations   | hypopharyngeal squamous cell carcinoma |            55 |            93 | Diseases & Disorders | Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene.                                                                                                                                                                                                                                                                               |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "from tabulate import tabulate\n",
    "\n",
    "# Load the CSV file\n",
    "ftrain = '../data/EUADR_target_disease.csv'\n",
    "df = pd.read_csv(ftrain, encoding='latin1', sep='\\t')\n",
    "\n",
    "# Display the first line to understand the structure\n",
    "with open(ftrain, 'r', encoding='latin1') as file:\n",
    "    first_line = file.readline()\n",
    "    print(\"First line of the file:\", first_line)\n",
    "\n",
    "# Display the column names to identify the one that corresponds to the entity association type\n",
    "print(\"Column names:\", df.columns)\n",
    "\n",
    "# Check for unique association types\n",
    "unique_association_types = df['ASSOCIATION_TYPE'].unique()\n",
    "print(\"Unique association types:\", unique_association_types)\n",
    "\n",
    "# Filter the DataFrame to exclude rows where the association type is NaN (if applicable)\n",
    "df_filtered = df[df['ASSOCIATION_TYPE'].notna()]\n",
    "\n",
    "# Display the filtered rows\n",
    "print(tabulate(df_filtered.head(15), headers='keys', tablefmt='grid'))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "First line of the file: \"ASSOCIATION_TYPE\"\t\"PMID\"\t\"NUM_SENTENCE\"\t\"ENTITY1_TEXT\"\t\"ENTITY1_INI\"\t\"ENTITY1_END\"\t\"ENTITY1_TYPE\"\t\"ENTITY2_TEXT\"\t\"ENTITY2_INI\"\t\"ENTITY2_END\"\t\"ENTITY2_TYPE\"\t\"SENTENCE\"\n",
      "\n",
      "Column names: Index(['ASSOCIATION_TYPE', 'PMID', 'NUM_SENTENCE', 'ENTITY1_TEXT',\n",
      "       'ENTITY1_INI', 'ENTITY1_END', 'ENTITY1_TYPE', 'ENTITY2_TEXT',\n",
      "       'ENTITY2_INI', 'ENTITY2_END', 'ENTITY2_TYPE', 'SENTENCE'],\n",
      "      dtype='object')\n",
      "Association types and their counts:\n",
      "+----+--------------------+---------+\n",
      "|    | Association Type   |   Count |\n",
      "+====+====================+=========+\n",
      "|  0 | PA                 |     213 |\n",
      "+----+--------------------+---------+\n",
      "|  1 | FA                 |      93 |\n",
      "+----+--------------------+---------+\n",
      "|  2 | SA                 |      30 |\n",
      "+----+--------------------+---------+\n",
      "\n",
      "Sample rows for association type 'SA':\n",
      "+-----+--------------------+----------+----------------+----------------+---------------+---------------+-----------------------------+----------------------------+---------------+---------------+----------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|     | ASSOCIATION_TYPE   |     PMID |   NUM_SENTENCE | ENTITY1_TEXT   |   ENTITY1_INI |   ENTITY1_END | ENTITY1_TYPE                | ENTITY2_TEXT               |   ENTITY2_INI |   ENTITY2_END | ENTITY2_TYPE         | SENTENCE                                                                                                                                                   |\n",
      "+=====+====================+==========+================+================+===============+===============+=============================+============================+===============+===============+======================+============================================================================================================================================================+\n",
      "|   0 | SA                 | 17241106 |             16 | LRP5           |            19 |            23 | Genes & Molecular Sequences | osteoporosis               |            80 |            92 | Diseases & Disorders | Our work supported LRP5 genetic variants as possible susceptibility factors for osteoporosis and fractures in humans.                                      |\n",
      "+-----+--------------------+----------+----------------+----------------+---------------+---------------+-----------------------------+----------------------------+---------------+---------------+----------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|   1 | SA                 | 17241106 |             17 | rs491347       |            20 |            28 | SNP & Sequence variations   | osteoporosis               |           108 |           120 | Diseases & Disorders | Especially, the SNP rs491347 and its strongly associated SNPs (e.g., rs1784235) could be important to human osteoporosis phenotypes.                       |\n",
      "+-----+--------------------+----------+----------------+----------------+---------------+---------------+-----------------------------+----------------------------+---------------+---------------+----------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|   2 | SA                 | 17241106 |             17 | rs1784235      |            69 |            78 | SNP & Sequence variations   | osteoporosis               |           108 |           120 | Diseases & Disorders | Especially, the SNP rs491347 and its strongly associated SNPs (e.g., rs1784235) could be important to human osteoporosis phenotypes.                       |\n",
      "+-----+--------------------+----------+----------------+----------------+---------------+---------------+-----------------------------+----------------------------+---------------+---------------+----------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  23 | SA                 | 17593927 |             11 | XRCC1          |             0 |             5 | Genes & Molecular Sequences | gastric cancer             |            61 |            75 | Diseases & Disorders | XRCC1 genotyping might make tailor chemotherapy possible for gastric cancer patients treated with oxaliplatin-based chemotherapy.                          |\n",
      "+-----+--------------------+----------+----------------+----------------+---------------+---------------+-----------------------------+----------------------------+---------------+---------------+----------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  32 | SA                 | 19035720 |              6 | rs42524        |             4 |            11 | SNP & Sequence variations   | IAs                        |            79 |            82 | Diseases & Disorders | The rs42524 polymorphism of COL1A2 could be a genetic risk factor for sporadic IAs among individuals of Chinese Han ethnicity.                             |\n",
      "+-----+--------------------+----------+----------------+----------------+---------------+---------------+-----------------------------+----------------------------+---------------+---------------+----------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  43 | SA                 | 19110417 |              2 | CYP1A1         |            56 |            62 | Genes & Molecular Sequences | HCC                        |            70 |            73 | Diseases & Disorders | However, the contribution of common genetic variants in CYP1A1 to the HCC risk in Chinese populations has not been thoroughly investigated.                |\n",
      "+-----+--------------------+----------+----------------+----------------+---------------+---------------+-----------------------------+----------------------------+---------------+---------------+----------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  50 | SA                 | 19110417 |             11 | CYP1A1         |            54 |            60 | Genes & Molecular Sequences | HCC                        |            97 |           100 | Diseases & Disorders | Our results suggested that common genetic variants in CYP1A1 may modulate the risk of developing HCC in the study population, particularly in non-smokers. |\n",
      "+-----+--------------------+----------+----------------+----------------+---------------+---------------+-----------------------------+----------------------------+---------------+---------------+----------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  86 | SA                 | 18708184 |              1 | NRG3           |            51 |            55 | Genes & Molecular Sequences | schizophrenia              |            65 |            78 | Diseases & Disorders | The study investigated the possible association of NRG3 gene and schizophrenia in a Han Chinese population.                                                |\n",
      "+-----+--------------------+----------+----------------+----------------+---------------+---------------+-----------------------------+----------------------------+---------------+---------------+----------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  98 | SA                 | 19098911 |              6 | NLRP3          |            31 |            36 | Genes & Molecular Sequences | Crohn's disease            |           130 |           145 | Diseases & Disorders | These results suggest that the NLRP3 region is also implicated in the susceptibility of more common inflammatory diseases such as Crohn's disease.         |\n",
      "+-----+--------------------+----------+----------------+----------------+---------------+---------------+-----------------------------+----------------------------+---------------+---------------+----------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "| 102 | SA                 | 19115152 |              4 | MDR1           |            32 |            36 | Genes & Molecular Sequences | inflammatory bowel disease |            93 |           119 | Diseases & Disorders | Therefore, the mutations of the MDR1 gene are thought to be related with the pathogenesis of inflammatory bowel disease.                                   |\n",
      "+-----+--------------------+----------+----------------+----------------+---------------+---------------+-----------------------------+----------------------------+---------------+---------------+----------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "\n",
      "Sample rows for association type 'FA':\n",
      "+----+--------------------+----------+----------------+-----------------------+---------------+---------------+-----------------------------+-----------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|    | ASSOCIATION_TYPE   |     PMID |   NUM_SENTENCE | ENTITY1_TEXT          |   ENTITY1_INI |   ENTITY1_END | ENTITY1_TYPE                | ENTITY2_TEXT          |   ENTITY2_INI |   ENTITY2_END | ENTITY2_TYPE         | SENTENCE                                                                                                                                                                                                                                                                                                                                                                                                                                           |\n",
      "+====+====================+==========+================+=======================+===============+===============+=============================+=======================+===============+===============+======================+====================================================================================================================================================================================================================================================================================================================================================================================================================================================+\n",
      "|  3 | FA                 | 18697826 |              0 | fetal haemoglobin     |            93 |           110 | Genes & Molecular Sequences | beta-thalassaemia     |           132 |           149 | Diseases & Disorders | The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia.                                                                                                                                                                                                                                                                                             |\n",
      "+----+--------------------+----------+----------------+-----------------------+---------------+---------------+-----------------------------+-----------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  6 | FA                 | 18697826 |              0 | HBS1L-MYB             |             4 |            13 | Genes & Molecular Sequences | beta-thalassaemia     |           132 |           149 | Diseases & Disorders | The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia.                                                                                                                                                                                                                                                                                             |\n",
      "+----+--------------------+----------+----------------+-----------------------+---------------+---------------+-----------------------------+-----------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  7 | FA                 | 18697826 |              0 | 6q23                  |            46 |            50 | Genes & Molecular Sequences | beta-thalassaemia     |           132 |           149 | Diseases & Disorders | The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia.                                                                                                                                                                                                                                                                                             |\n",
      "+----+--------------------+----------+----------------+-----------------------+---------------+---------------+-----------------------------+-----------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  8 | FA                 | 18697826 |              7 | HbF                   |            87 |            90 | Genes & Molecular Sequences | HBB disorders         |           196 |           209 | Diseases & Disorders | Functional studies to unravel the biological significance of this region in regulating HbF production is clearly indicated, which may lead to new strategies to modify the disease course of severe HBB disorders.                                                                                                                                                                                                                                 |\n",
      "+----+--------------------+----------+----------------+-----------------------+---------------+---------------+-----------------------------+-----------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "| 10 | FA                 | 18322311 |              7 | IL-1alpha TT -889     |            35 |            52 | SNP & Sequence variations   | multiple sclerosis    |           406 |           424 | Diseases & Disorders | On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), TNFalpha G -308 allele (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian multiple sclerosis patients. |\n",
      "+----+--------------------+----------+----------------+-----------------------+---------------+---------------+-----------------------------+-----------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "| 15 | FA                 | 18347176 |              9 | T393C                 |             4 |             9 | SNP & Sequence variations   | hypopharyngeal cancer |           130 |           151 | Diseases & Disorders | The T393C SNP could be considered as a genetic marker to predict the clinical course of patients suffering from oropharyngeal and hypopharyngeal cancer.                                                                                                                                                                                                                                                                                           |\n",
      "+----+--------------------+----------+----------------+-----------------------+---------------+---------------+-----------------------------+-----------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "| 17 | FA                 | 18347176 |              3 | T393C                 |            28 |            33 | SNP & Sequence variations   | oropharyngeal         |           121 |           134 | Diseases & Disorders | The prognostic value of the T393C SNP was evaluated in an unselected series of patients treated with curative intent for oropharyngeal and hypopharyngeal squamous cell carcinomas, including all tumor stages with different therapeutic regimens.                                                                                                                                                                                                |\n",
      "+----+--------------------+----------+----------------+-----------------------+---------------+---------------+-----------------------------+-----------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "| 18 | FA                 | 17430902 |              3 | Wnt                   |            69 |            72 | Genes & Molecular Sequences | colon cancer          |            25 |            37 | Diseases & Disorders | However, the majority of colon cancer cells have deregulation of the Wnt/beta-catenin pathway.                                                                                                                                                                                                                                                                                                                                                     |\n",
      "+----+--------------------+----------+----------------+-----------------------+---------------+---------------+-----------------------------+-----------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "| 19 | FA                 | 17430902 |              0 | Krppel-like factor 5 |            87 |           108 | Genes & Molecular Sequences | colon cancer          |            51 |            63 | Diseases & Disorders | Lysophosphatidic acid facilitates proliferation of colon cancer cells via induction of Krppel-like factor 5.                                                                                                                                                                                                                                                                                                                                      |\n",
      "+----+--------------------+----------+----------------+-----------------------+---------------+---------------+-----------------------------+-----------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "| 28 | FA                 | 19097922 |              1 | CYP4F2                |            45 |            51 | Genes & Molecular Sequences | MI                    |           139 |           141 | Diseases & Disorders | This study assessed associations between the CYP4F2 gene and myocardial infarction (MI), using a haplotype-based case-control study of 234 MI patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).                                                                                                                                                                   |\n",
      "+----+--------------------+----------+----------------+-----------------------+---------------+---------------+-----------------------------+-----------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "\n",
      "Sample rows for association type 'PA':\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|    | ASSOCIATION_TYPE   |     PMID |   NUM_SENTENCE | ENTITY1_TEXT                    |   ENTITY1_INI |   ENTITY1_END | ENTITY1_TYPE                | ENTITY2_TEXT                           |   ENTITY2_INI |   ENTITY2_END | ENTITY2_TYPE         | SENTENCE                                                                                                                                                                                                                                                                                                                                                                                                                                           |\n",
      "+====+====================+==========+================+=================================+===============+===============+=============================+========================================+===============+===============+======================+====================================================================================================================================================================================================================================================================================================================================================================================================================================================+\n",
      "|  4 | PA                 | 18697826 |              1 | HbF                             |            19 |            22 | Genes & Molecular Sequences | HBB disorders                          |            64 |            77 | Diseases & Disorders | Fetal haemoglobin (HbF) level modifies the clinical severity of HBB disorders.                                                                                                                                                                                                                                                                                                                                                                     |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  5 | PA                 | 18697826 |              1 | Fetal haemoglobin               |             0 |            17 | Genes & Molecular Sequences | HBB disorders                          |            64 |            77 | Diseases & Disorders | Fetal haemoglobin (HbF) level modifies the clinical severity of HBB disorders.                                                                                                                                                                                                                                                                                                                                                                     |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "|  9 | PA                 | 18322311 |              0 | TNFalpha gene polymorphisms     |            16 |            43 | Genes & Molecular Sequences | multiple sclerosis                     |            69 |            87 | Diseases & Disorders | IL-1, IL-1R and TNFalpha gene polymorphisms in Iranian patients with multiple sclerosis.                                                                                                                                                                                                                                                                                                                                                           |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "| 11 | PA                 | 18322311 |              7 | TNFalpha G -308 allele          |           138 |           160 | Genes & Molecular Sequences | multiple sclerosis                     |           406 |           424 | Diseases & Disorders | On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), TNFalpha G -308 allele (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian multiple sclerosis patients. |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "| 12 | PA                 | 18322311 |              0 | IL-1                            |             0 |             4 | Genes & Molecular Sequences | multiple sclerosis                     |            69 |            87 | Diseases & Disorders | IL-1, IL-1R and TNFalpha gene polymorphisms in Iranian patients with multiple sclerosis.                                                                                                                                                                                                                                                                                                                                                           |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "| 13 | PA                 | 18347176 |              0 | T393C polymorphism of the GNAS1 |           127 |           158 | SNP & Sequence variations   | oropharyngeal                          |            37 |            50 | Diseases & Disorders | Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene.                                                                                                                                                                                                                                                                               |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "| 14 | PA                 | 18347176 |              0 | T393C polymorphism of the GNAS1 |           127 |           158 | SNP & Sequence variations   | hypopharyngeal squamous cell carcinoma |            55 |            93 | Diseases & Disorders | Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene.                                                                                                                                                                                                                                                                               |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "| 16 | PA                 | 18347176 |              9 | T393C                           |             4 |             9 | SNP & Sequence variations   | oropharyngeal                          |           112 |           125 | Diseases & Disorders | The T393C SNP could be considered as a genetic marker to predict the clinical course of patients suffering from oropharyngeal and hypopharyngeal cancer.                                                                                                                                                                                                                                                                                           |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "| 20 | PA                 | 17430902 |              2 | beta-catenin                    |            99 |           111 | Genes & Molecular Sequences | colon cancer                           |            57 |            69 | Diseases & Disorders | A recent study showed that LPA-mediated proliferation of colon cancer cells requires activation of beta-catenin.                                                                                                                                                                                                                                                                                                                                   |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "| 21 | PA                 | 18930278 |              6 | CYP3A5 A6986G genotype *3/*3    |            29 |            57 | Genes & Molecular Sequences | leukocytopenia                         |           211 |           225 | Diseases & Disorders | On multivariate analysis the CYP3A5 A6986G genotype *3/*3 (OR 8.205, 95% CI 1.616-41.667, p = 0.011) and smaller number of treatment cycles (OR 0.156, 95% CI 0.037-0.659, p = 0.011) were independent factors for leukocytopenia (grade 3 or greater) throughout the period of chemotherapy.                                                                                                                                                      |\n",
      "+----+--------------------+----------+----------------+---------------------------------+---------------+---------------+-----------------------------+----------------------------------------+---------------+---------------+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
      "\n",
      "Sample rows for association type 'nan':\n",
      "+--------------------+--------+----------------+----------------+---------------+---------------+----------------+----------------+---------------+---------------+----------------+------------+\n",
      "| ASSOCIATION_TYPE   | PMID   | NUM_SENTENCE   | ENTITY1_TEXT   | ENTITY1_INI   | ENTITY1_END   | ENTITY1_TYPE   | ENTITY2_TEXT   | ENTITY2_INI   | ENTITY2_END   | ENTITY2_TYPE   | SENTENCE   |\n",
      "+====================+========+================+================+===============+===============+================+================+===============+===============+================+============+\n",
      "+--------------------+--------+----------------+----------------+---------------+---------------+----------------+----------------+---------------+---------------+----------------+------------+\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "from tabulate import tabulate\n",
    "\n",
    "# Load the CSV file\n",
    "ftrain = '../data/EUADR_target_disease.csv'\n",
    "df = pd.read_csv(ftrain, encoding='latin1', sep='\\t')\n",
    "\n",
    "# Display the first line to understand the structure\n",
    "with open(ftrain, 'r', encoding='latin1') as file:\n",
    "    first_line = file.readline()\n",
    "    print(\"First line of the file:\", first_line)\n",
    "\n",
    "# Display the column names to identify the one that corresponds to the entity association type\n",
    "print(\"Column names:\", df.columns)\n",
    "\n",
    "# Get unique association types and their counts\n",
    "association_type_counts = df['ASSOCIATION_TYPE'].value_counts()\n",
    "print(\"Association types and their counts:\")\n",
    "print(tabulate(association_type_counts.reset_index(), headers=['Association Type', 'Count'], tablefmt='grid'))\n",
    "\n",
    "# If you want to see a sample of rows for each association type\n",
    "# Display the first 10 rows for each unique association type\n",
    "for assoc_type in df['ASSOCIATION_TYPE'].unique():\n",
    "    print(f\"\\nSample rows for association type '{assoc_type}':\")\n",
    "    sample_df = df[df['ASSOCIATION_TYPE'] == assoc_type].head(10)\n",
    "    print(tabulate(sample_df, headers='keys', tablefmt='grid'))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Column names: Index(['ASSOCIATION_TYPE', 'PMID', 'NUM_SENTENCE', 'ENTITY1_TEXT',\n",
      "       'ENTITY1_INI', 'ENTITY1_END', 'ENTITY1_TYPE', 'ENTITY2_TEXT',\n",
      "       'ENTITY2_INI', 'ENTITY2_END', 'ENTITY2_TYPE', 'SENTENCE'],\n",
      "      dtype='object')\n",
      "Association type 'SA' is not present in the data.\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "\n",
    "# Load the CSV file\n",
    "ftrain = '../data/EUADR_target_disease.csv'\n",
    "df = pd.read_csv(ftrain, encoding='latin1', sep='\\t')\n",
    "\n",
    "# Display the column names to identify the one that corresponds to the entity association type\n",
    "print(\"Column names:\", df.columns)\n",
    "\n",
    "# Check if 'SA' exists in the 'ASSOCIATION_TYPE' column\n",
    "association_types = df['ASSOCIATION_TYPE'].unique()\n",
    "if 'NA' in association_types:\n",
    "    print(\"Association type 'SA' is present in the data.\")\n",
    "else:\n",
    "    print(\"Association type 'SA' is not present in the data.\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Read Data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Input File Reading\n",
      "train_size 355\n"
     ]
    }
   ],
   "source": [
    "from tabulate import tabulate\n",
    "Tr_sent_contents, Tr_entity1_list, Tr_entity2_list, Tr_sent_lables = utils.dataRead_befree_EUADR(ftrain)\n",
    "# Convert the lists to a DataFrame\n",
    "df = pd.DataFrame({\n",
    "    'Sent Contents': Tr_sent_contents,\n",
    "    'Entity 1': Tr_entity1_list,\n",
    "    'Entity 2': Tr_entity2_list,\n",
    "    'Sent Labels': Tr_sent_lables\n",
    "})\n",
    "\n",
    "\n",
    "# Display the first 10 rows of the DataFrame as a table\n",
    "print(tabulate(df.head(4), headers='keys', tablefmt='grid'))\n",
    "\n",
    "Tr_word_list, Tr_d1_list, Tr_d2_list  = utils.get_wordList_and_distances_befree(Tr_sent_contents)\n",
    "\n",
    "df = pd.DataFrame({\n",
    "    'word list': Tr_word_list,\n",
    "    'd1 list': Tr_d1_list,\n",
    "    'd2 list': Tr_d2_list,\n",
    "})\n",
    "\n",
    "\n",
    "# Display the first 10 rows of the DataFrame as a table\n",
    "print(tabulate(df.head(4), headers='keys', tablefmt='grid'))\n",
    "\n",
    "print (\"train_size\", len(Tr_word_list))\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Prepare Lable Matrix"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Y : is positive association \n",
    "# N: is negative association\n",
    "label_dict = {'FA':0, 'NA':0,'PA':1,'SA':1}\n",
    "\n",
    "Y_t = mapLabelToId_befree_EUADR(Tr_sent_lables, label_dict)\n",
    "Y_train = np.zeros((len(Y_t), 2))\n",
    "for i in range(len(Y_t)):\n",
    "    Y_train[i][Y_t[i]] = 1.0"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Generate Word and Position Embedding Vectors"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Word Embedding"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found 1355 unique words (10062 in total)\n",
      "word dictonary length 1355\n",
      "Reading word vectors\n",
      "Loaded 1356 pretrained embeddings.\n",
      "number of unknown word in word embedding 814\n",
      "W_train 355\n",
      "word_vectors 1355\n"
     ]
    }
   ],
   "source": [
    "word_dict, word_to_id, id_to_word = word_mapping(Tr_word_list)\n",
    "\n",
    "print( \"word dictonary length\", len(word_dict))\n",
    "\n",
    "# Word Embedding\n",
    "word_vectors = readWordEmb(word_dict,id_to_word,word_to_id, wefile, embSize,limit=1356)\n",
    "W_train =   mapWordToId(Tr_word_list, word_to_id)\n",
    "print(\"W_train\",len(W_train))\n",
    "print(\"word_vectors\",len(word_vectors))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Position Embedding"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "d1_dict = makeDistanceList([Tr_d1_list])\n",
    "d2_dict = makeDistanceList([Tr_d2_list])\n",
    "d1_train = mapWordToId_list(Tr_d1_list, d1_dict)\n",
    "d2_train = mapWordToId_list(Tr_d2_list, d2_dict)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Pad Embdding Vectors"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "sentMax 102\n",
      "W_train 355\n",
      "d1_train 355\n",
      "d2_train 355\n"
     ]
    }
   ],
   "source": [
    "train_sent_lengths= findSentLengths([Tr_word_list])\n",
    "\n",
    "sentMax =max(max(train_sent_lengths[:]))\n",
    "\n",
    "W_train, d1_train, d2_train = paddData([W_train, d1_train, d2_train ], sentMax,padd_num=1354)\n",
    "print(\"sentMax\",sentMax)\n",
    "print(\"W_train\",len(W_train))\n",
    "print(\"d1_train\",len(d1_train))\n",
    "print(\"d2_train\",len(d2_train))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Save Prepared Data as Pickle File"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open('../data/pickles/befree_EUADR_2class_PubMed-and-PMC-w2v.pickle', 'wb') as handle:\n",
    "    pickle.dump(W_train, handle)\n",
    "    pickle.dump(d1_train, handle)\n",
    "    pickle.dump(d2_train, handle)    \n",
    "    pickle.dump(Y_train, handle)\n",
    "    pickle.dump(Tr_word_list, handle)\n",
    "    pickle.dump(word_vectors, handle)\n",
    "    pickle.dump(word_dict, handle)\n",
    "    pickle.dump(d1_dict, handle)\n",
    "    pickle.dump(d2_dict, handle)\n",
    "    pickle.dump(label_dict, handle) \n",
    "    pickle.dump(sentMax, handle)\n",
    "    \n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
